( MENAFN - JCN NewsWire) FDA Accepts LEQEMBI (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the treatment of Early Alzheimer's disease LEQEMBI is the only ...

DATROWAY® (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+ ...

Chest congestion from asthma can cause symptoms like coughing ... given their potential for causing bronchospasm. In some situations, your healthcare provider may recommend a mucolytic for a short ...

What are the symptoms of emphysema? - Understanding the condition is the first step towards taking control of your lung ...

Some may relieve factors that contribute to dyspnea, such as bronchospasm (bronchodilators), or fluid overload (diuretics). Others can help provide symptom relief directly, including opioids ...

But while many folks do improve at home thanks to a combination of medication, rest, hydration and time, others require ...

Volume of distribution at steady state (L/kg) 187 194 194 Table 2. Changes in cough-related symptoms following treatment with levocloperastine 30, 60 and 120 mg/day for 6 days in patients with ...

Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved LUMAKRAS® (sotorasib) in combination with Vectibix® (panitumumab) for the treatment of adult patients with KRAS G12C ...

Pivotal Study Demonstrated the Combination More Than Doubled Progression-Free Survival Compared to Investigated SOC THOUSAND OAKS, Calif., Jan. 17, 2025 /PRNewswire/ ...

Pneumonia symptoms can vary based on the cause and severity of the lung infection. For some, it might feel similar to the flu or be barely noticeable. For others, pneumonia can cause severe ...

Increasing Prevalence of Asthma and COPD: The rising incidence of asthma and chronic obstructive pulmonary disease (COPD) ...